- Home
- GAUZ vs INZY Comparison
GAUZ vs INZY Comparison
Compare GAUZ & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAUZ
- INZY
- Stock Information
- Founded
- GAUZ 2009
- INZY 2015
- Country
- GAUZ Israel
- INZY United States
- Employees
- GAUZ N/A
- INZY N/A
- Industry
- GAUZ Industrial Machinery/Components
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- GAUZ Miscellaneous
- INZY Health Care
- Exchange
- GAUZ Nasdaq
- INZY Nasdaq
- Market Cap
- GAUZ 193.8M
- INZY 188.2M
- IPO Year
- GAUZ 2024
- INZY 2020
- Fundamental
- Price
- GAUZ $10.77
- INZY $1.36
- Analyst Decision
- GAUZ Strong Buy
- INZY Strong Buy
- Analyst Count
- GAUZ 4
- INZY 8
- Target Price
- GAUZ $16.25
- INZY $17.75
- AVG Volume (30 Days)
- GAUZ 57.1K
- INZY 1.0M
- Earning Date
- GAUZ 02-10-2025
- INZY 03-11-2025
- Dividend Yield
- GAUZ N/A
- INZY N/A
- EPS Growth
- GAUZ N/A
- INZY N/A
- EPS
- GAUZ N/A
- INZY N/A
- Revenue
- GAUZ $94,346,000.00
- INZY N/A
- Revenue This Year
- GAUZ $34.50
- INZY N/A
- Revenue Next Year
- GAUZ $32.32
- INZY N/A
- P/E Ratio
- GAUZ N/A
- INZY N/A
- Revenue Growth
- GAUZ 29.76
- INZY N/A
- 52 Week Low
- GAUZ $6.78
- INZY $1.24
- 52 Week High
- GAUZ $17.10
- INZY $7.80
- Technical
- Relative Strength Index (RSI)
- GAUZ N/A
- INZY 29.28
- Support Level
- GAUZ N/A
- INZY $1.35
- Resistance Level
- GAUZ N/A
- INZY $1.62
- Average True Range (ATR)
- GAUZ 0.00
- INZY 0.13
- MACD
- GAUZ 0.00
- INZY 0.04
- Stochastic Oscillator
- GAUZ 0.00
- INZY 32.89
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a integrated light and vision control company, Its products include suspended particle device, or SPD, and liquid crystal, or LC, films for smart glass applications, as well as camera monitoring systems, or CMS, and other advanced driver assistance systems, or ADAS, solutions. It has three operating segments. Architecture and automotive segment focuses on sales that enable OEMs to incorporate the Company's technology in glass rooftops, side windows and windshields. Safety tech segment focuses on sales of advanced driver assistance systems for buses, coaches, recreational vehicles and specific vehicles. Aeronautics segment focuses on the sale of shading and cabin management systems in private and commercial aircraft and helicopters. Key revenue is generated from Aeronauctis.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.